DECRYPTION
Is this the guarantee of a "European" vaccine against Covid-19? In any case, a sizeable agreement was signed on Saturday June 13: Germany, France, Italy and the Netherlands have the guarantee of the pharmaceutical group AstraZeneca that it will supply between 300 and 400 million doses of vaccine when discovered. A way for the European Union to secure access to a possible vaccine, while the position taken by Sanofi, on a priority given to the United States, the main financier of their research, had caused much reaction.
>> LIVE - Coronavirus: follow the development of the situation on Sunday June 14
Deliveries before the end of 2020?
His code name? AZD 1222. If it is too early to speak of "the" vaccine since its efficacy is not yet proven, the studies are sufficiently advanced to give hope of positive results and sufficiently credible to launch this "inclusive vaccine alliance", which would be able to supply all European countries wishing to join the project.
CORONAVIRUS ESSENTIALS
> Coronavirus: "We can largely release the pressure", according to an epidemiologist
> Coronavirus: the situation is "getting worse" worldwide, according to the WHO
> Economic crisis: "There will be two shocks, one on unemployment and one for young people"
> The rant of the pedagogue Philippe Meirieu against the distance school
> Coronavirus: 5 mistakes not to make with your mask
> It's a good time to take a flight to Europe!
Bercy and the Ministry of Health have indicated that this agreement in principle could guarantee up to 400 million doses of vaccine at cost price, with first deliveries expected before the end of 2020, much earlier than all the calendars mentioned so far, which were rather based on summer 2021 at best.
Already a SARS vaccine
If the AstraZeneca group, resulting from a merger between English and Swedish laboratories, raises so many hopes, it is because it has already developed vaccines against SARS in particular. France and the other signatory countries clarified that this negotiation with the European Commission was not exclusive. Others are continuing with several laboratories in order to maximize the chances of having a vaccine in sufficient quantity and at the best cost as soon as possible.